O. Vetterlein

Comprehensive pharmacokinetics of a humanized antibody and analysis of residual anti-idiotypic responses.

A. Nesbitt, S. Stephens, M. Sopwith, 1995, Immunology.

The S228P Mutation Prevents in Vivo and in Vitro IgG4 Fab-arm Exchange as Demonstrated using a Combination of Novel Quantitative Immunoassays and Physiological Matrix Preparation

O. Vetterlein, S. Peters, Joby Jose, 2015, The Journal of Biological Chemistry.

F(ab')2 molecules made from Escherichia coli produced Fab' with hinge sequences conferring increased serum survival in an animal model.

A. Suitters, P. Stephens, D. Humphreys, 1998, Journal of immunological methods.

The engineered human anti-tumor necrosis factor-alpha antibody CDP571 inhibits inflammatory pathways but not T cell activation in patients with rheumatoid arthritis.

G. Kingsley, D. Isenberg, R. Eastell, 1999, Journal of Rheumatology.